Gaithersburg Based Novavax Could Start Making Omicron-Specific COVID-19 Vaccine By January
Gaithersburg based Novavax announced that today that they could begin commercial manufacturing of a COVID-19 vaccine for the Omicron coronavirus variant by January of 2022. Novavax is currently testing whether or not its current vaccine works against the Omicron variant.